Oh look, we made a new spinout company! Repeat academic founder Simon Boulton is planning to exploit the weird trick that cancer cells use to keep replicating indefinitely www.crick.ac.uk/news/2026-02...
With the launch of ALTx, a new company focussed on exploiting this ability, scientists hope to turn cancer’s borrowed time into a vulnerability.
